Ikezoe T, Noji H, Ueda Y, Kanda Y, Okamoto S, Usuki K, Matsuda T, Akiyama H, Shimono A, Yonemura Y, Kawaguch T, Chiba S, Kanakura Y, Nishimura J, Ninomiya H, Obara N.

Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab:post-marketing surveillance in Japan.

Int J Hematol 115(4):470-480,2022. doi: 10.1007/s12185-022-03287-y.

https://pubmed.ncbi.nlm.nih.gov/35146630/

Nagata A, Otsuka Y, Konuma R, Adachi H, Wada A, Kishida Y, Konishi T, Yamada Y, Nagata R, Noguchi Y, Marumo A, Mukae J, Toya T, Igarashi A, Najima Y, Kobayashi T, Sakamaki H, Ohashi K, Doki N.

Weight-adjusted urinary creatinine excretion predicts transplant outcomes in adult patients with acute myeloid leukemia in complete remission.

Kawano Y, Sasano T, Arima Y, Kushima S, Tsujita K, Matsuoka M, Hata H.

A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cells.

Biochem Biophys Res Commun 587: 153-159,2022. doi: 10.1016/j.bbrc.2021.11.102.

https://pubmed.ncbi.nlm.nih.gov/34875534/

Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Iguchi D, Izutsu K.

Two-year outcomes of tirabrutinib monotherapy in Waldenström’s macroglobulinemia.

Tanaka N, Mori S, Kiyotani K, Ota Y, Gotoh O, Kusumoto S, Nakano N, Suehiro Y, Ito A, Choi I, Ohtsuka E, Hidaka M, Nosaka K, Yoshimitsu M, Imaizumi Y, Iida S, Utsunomiya A, Noda T, Nishikawa H, Ueda R, Ishida T.

Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma.

Haematologica 1;107(10):2418-2431.doi: 10.3324/haematol.2021.280352.

https://pubmed.ncbi.nlm.nih.gov/35417939/

Masayuki Amano, Ravikiran S Yedidi, Pedro Miguel Salcedo-Gómez, Hironori Hayashi, Kazuya Hasegawa, Cuthbert D Martyr, Arun K Ghosh, Hiroaki Mitsuya.

Fluorine-Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-Brain Barrier (BBB) Penetration Property of Novel Central Nervous System (CNS)-targeting HIV-1 Protease Inhibitors In Vitro.

Antimicrob Agents Chemother. 2022 Jan 3; AAC0171521. doi: 10.1128/AAC.01715-21.

https://journals.asm.org/doi/10.1128/AAC.01715-21

https://pubmed.ncbi.nlm.nih.gov/34978889/

Oka K, Matsumoto A, Tetsuka N, Morioka H, Iguchi M, Ishiguro N, Nagamori T, Takahashi S, Saito N, Tokuda K, Igari H, Fujikura Y, Kato H, Kanai S, Kusama F, Iwasaki H, Furuhashi K, Baba H, Nagao M, Nakanishi M, Kasahara K, Kakeya H, Chikumi H, Ohge H, Azuma M, Tauchi H, Shimono N, Hamada Y, Takajo I, Nakata H, Kawamura H, Fujita J.

apan Infection Prevention and Control Conference for National and Public University Hospitals. Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan.

Kidoh M, Oda S, Takashio S, Hirakawa K, Kawano Y, Shiraishi S, Hayashi H, Nakaura T, Nagayama Y, Funama Y, Ueda M, Tsujita K, Hirai T.

CT extracellular volume fraction versus myocardium-to-lumen signal ratio for cardiac amyloidosis.

Radiology 306(3):e220542,2022.doi: 10.1148/radiol.220542.

https://pubmed.ncbi.nlm.nih.gov/36255307/

Higuchi Y, Yasunaga JI, Matsuoka M.

HTLV-1’s foxy strategy for survival and Transmission.

Front Virol doi: 10.3389/fviro.2021.792659,2022.

https://www.frontiersin.org/articles/10.3389/fviro.2021.792659/full

Rajib S.A, Ogi Y, Hossain M.B, Ikeda T, Tanaka E, Kawaguchi T, Satou Y.

A SARS-CoV-2 Delta variant containing mutation in the probe binding regions used for RT-qPCR test in Japan exhibited atypical PCR amplification and might induce false negative result.

J Infect Chemother 28(5):669-677,2022. doi: 10.1016/j.jiac.2022.01.019

https://pubmed.ncbi.nlm.nih.gov/35144878/

Fuji S,Yasunaga JI, Watanabe E, Matsuoka M, Uchimaru K, Ishikawa J.

Pseudo-progression of adult T-cell leukemia-lymphoma after cord blood transplantation.

Haematologica 1;107(11):2756-2759,2022.doi: 10.3324/haematol.2022.281175.

https://pubmed.ncbi.nlm.nih.gov/35734929/

Katsuya H, Cook LBM, Rowan AG, Melamed A, Turpin J, Ito J, Islam S, Miyazato P, Jek Yang Tan B, Matsuo M, Miyakawa T, Nakata H, Matsushita S, Taylor GP, Bangham CRM, Kimura S, Satou Y.

Clonality of HIV-1- and HTLV-1-Infected Cells in Naturally Coinfected Individuals.

Matsuo M, Ueno T, Monde K, Sugata K, Tan BJY, Rahman A, Miyazato P, Uchiyama K, Islam S, Katsuya H, Nakajima S, Tokunaga M, Nosaka K, Hata H, Utsunomiya A, Fujisawa JI, Satou Y.

Identification and characterization of a novel enhancer in the HTLV-1 proviral genome.

Ogawa H, Konishi T, Najima Y, Kito S, Hashimoto S, Kato C, Sakai S, Kanbara Y, Atsuta Y, Konuma R, Wada A, Murakami D, Nakasima S, Uchibori Y, Onai D, Hamamura A, Nishijima A, Shingai N, Toya T, Shimizu H, Kobayashi T, Ohashi K, Doki N, Murofushi KN.

Phase I trial of myeloablative conditioning with 3-day total marrow and lymphoid irradiation for leukemia.

Nosaka K, Kusumoto S, Nakano N, Choi I, Yoshimitsu M, Imaizumi Y, Hidaka M, Sasaki H, Makiyama J, Ohtsuka E, Jo T, Ogata M, Ito A, Yonekura K, Tatetsu H, Kato T, Kawakita T, Suehiro Y, Ishitsuka K, Iida S, Matsutani T, Utsunomiya A, Ueda R, Ishida T.

Clinical significance of the immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells of adult T-cell leukemia-lymphoma patients receiving mogamulizumab.

Br J Haematol 196(3):629-638,2022. doi: 10.1111/bjh.17895. Epub 2021 Oct 10.

https://pubmed.ncbi.nlm.nih.gov/34632569/

Ghosh AK, Kovela S, Sharma A, Shahabi D, Ghosh AK, Hopkins DR, Yadav M, Johnson ME, Agniswamy J, Wang YF, Hattori SI, Higashi-Kuwata N, Aoki M, Amano M, Weber IT, Mitsuya H.

Design, Synthesis and X-ray Structural Studies of Potent HIV-1 Protease Inhibitors Containing C-4 Substituted Tricyclic Hexahydro-furofuran Derivatives as P2 Ligands.

ChemMedChem doi: 10.1002/cmdc.202200058,2022.  doi: 10.1002/cmdc.202200058.

https://pubmed.ncbi.nlm.nih.gov/35170223/

Nishiyama-Fujita Y, Nakazato T, Iriyama N, Tokuhira M, Ishikawa M, Sato E, Takaku T, Sugimoto K, Fujita H, Fujioka I, Tsuchiya S, Kimura Y, Iwanaga E, Komatsu N, Asou N, Kizaki M, Hatta Y, Kawaguchi T.

Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors.

Ann Med 54(1):1244-1254.doi: 10.1080/07853890.2022.2069280.

https://pubmed.ncbi.nlm.nih.gov/35486442/

Kogure Y, Kameda T, Koya J, Yoshimitsu M, Nosaka K, Yasunaga JI, Imaizumi Y, Watanabe M, Saito Y, Ito Y, McClure MB, Tabata M, Shingaki S, Yoshifuji K, Chiba K, Okada A, Kakiuchi N, Nannya Y, Kamiunten A, Tahira Y, Akizuki K, Sekine M, Shide K, Hidaka T, Kubuki Y, Kitanaka A, Hidaka M, Nakano N, Utsunomiya A, Sica RA, Acuna-Villaorduna A, Janakiram M, Shah UA, Ramos JC, Shibata T, Takeuchi K, Takaori-Kondo A, Miyazaki Y, Matsuoka M, Ishitsuka K, Shiraishi Y, Miyano S, Ogawa S, Ye BH, Shimoda K, Kataoka K.

Whole-genome landscape of adult T-cell leukemia/lymphoma.

Blood 139(7):967-982,2022. doi: 10.1182/blood.2021013568.

https://pubmed.ncbi.nlm.nih.gov/34695199/

Kawano Y, Hata H, Takashio S, Tsujita K, Ueda M, Matsuoka M.

Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myeloma

Br J Haematol ,2022. doi: 10.1111/bjh.18234. Online ahead of print.

https://pubmed.ncbi.nlm.nih.gov/35524546/

Ishida T, Ito S, Tanaka J, Uchiyama M, Kawano Y, Moreau P, Martin T, Risse ML, Tada K, Suzuki K, Ishizawa K.

Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomised, open label, phase 3 IKEMA study.

Jpn J Clin Oncol 52(12):1446-1449,2022.doi: 10.1093/jjco/hyac137.

https://pubmed.ncbi.nlm.nih.gov/36073950/

Fuchida SI, Kawamura K, Sunami K, Tsukada N, Fujii S, Ohkawara H, Usuki K, Wake A, Endo S, Ishiyama K, Ueda Y, Nakamura Y, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, Takamatsu H.

Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Transplant Cell Ther 28(2):76-82,2022. doi: 10.1016/j.jtct.2021.10.021

https://pubmed.ncbi.nlm.nih.gov/34774818/

Kim K, Min CK, Koh Y, Ishizawa K, Kim SH, Ito S, Tanaka J, Uchiyama M, Kawano Y, Kim JS, Moreau P, Martin T, Dong Y, Risse ML, Suzuki K.

Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysis.

Int J Hematol 116(4):553-562,2022.doi: 10.1007/s12185-022-03378-w.

https://pubmed.ncbi.nlm.nih.gov/35578151/

Konishi T, Ogawa H, Najima Y, Hashimoto S, Kito S, Atsuta Y, Wada A, Adachi H, Konuma R, Kishida Y, Nagata A, Yamada Y, Kaito S, Mukae J, Marumo A, Noguchi Y, Shingai N, Toya T, Igarashi A, Shimizu H, Kobayashi T, Ohashi K, Doki N, Murofushi KN.

Outcomes of allogeneic haematopoietic stem cell transplantation with intensity-modulated total body irradiation by helical tomotherapy: a 2-year prospective follow-up study.

Fuchida S, Kawamura K, Sunami K, Tsukada N, Fujii S, Ohkawara H, Usuki K, Wake A, Endo S, Ishiyama K, Ueda Y, Nakamura Y, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, Takamatsu H.

Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Transplant Cell Ther 28(2):76-82,2022.  doi: 10.1016/j.jtct.2021.10.021.

https://pubmed.ncbi.nlm.nih.gov/34774818/